title: [Comparison of clinical results between TUR-P and holmium laser enucleation of the prostate (HoLEP) based on the initial experience].
abstract: OBJECTIVE
  We compared the surgical results between holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TUR-P) for the treatment of men with benign prostatic hyperplasia (BPH).
  
  
  METHODS
  A total of 87 patients with symptomatic BPH were analysed. HoLEP was performed on 46 men (mean age 68.2 +/- 7.5 years old) from December 2005 to February 2007, and TUR-P was performed on 41 men (mean age 69.2 +/- 7.3 years old) from April 2004 to March 2006.
  
  
  RESULTS
  Both groups were comparable in terms of age, pre-operative IPSS, QOL index, urodynamic study results and prostate volume. During operation, decrease in hemoglobin was less in the HoLEP group than in the TUR-P group (1.15 +/- 1.2 vs 1.91 +/- 1.3 g/dl p < 0.05). The operation time was significantly longer in the HoLEP group than in the TUR-P group (161.9 +/- 65.0 vs. 118.3 +/- 36.9 minutes p < 0.001). Mean resected weight was 29.3 +/- 13.3 g (10-55) in the TUR-P group and 34.8 +/- 33.4 g (5-148) in the HoLEP group (p = 0.337). The catheterization period (52.1 +/- 29.6 vs. 115.2 +/- 27.5 hour p < 0.001) and hospital stay (6.6 +/- 2.3 vs. 9.4 +/- 2.2 days p < 0.001) were significantly shorter in the HoLEP group than in the TUR-P group. At follow up, Qmax, average flow rate and post void residual urine (PVR) in two groups improved significantly, and these parameters were not significantly different between the groups after 3 months.
  
  
  CONCLUSIONS
  Both TUR-P and HoLEP were effective in relieving BOO. The estimated blood loss, a catheterization time and hospitalization were less or shorter in the HoLEP group. HoLEP may be a good alternative to the conventional transurethral electrocautery resection of the prostate for symptomatic BPH.
authors.affiliation: Department of Urology, Kyorin University School of Medicine.
authors.forename: Toshihide
authors.initials: T
authors.lastname: Shishido
authors.forename: Kaori
authors.initials: K
authors.lastname: Enomoto
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Fujita
authors.forename: Atsushi
authors.initials: A
authors.lastname: Suzuki
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Hayashi
authors.forename: Masafumi
authors.initials: M
authors.lastname: Nomura
authors.forename: Naoshi
authors.initials: N
authors.lastname: Itaya
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Tanbo
authors.forename: Kazuyoshi
authors.initials: K
authors.lastname: Watanabe
authors.forename: Haruhisa
authors.initials: H
authors.lastname: Noda
authors.forename: Takatsugu
authors.initials: T
authors.lastname: Okegawa
authors.forename: Kikuo
authors.initials: K
authors.lastname: Nutahara
authors.forename: Eiji
authors.initials: E
authors.lastname: Higashihara
mesh_terms: D000368:Aged; D006801:Humans; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000503:physiopathology / Q000601:surgery*; D012189:Retrospective Studies; D020728:Transurethral Resection of Prostate; D016896:Treatment Outcome; D014546:Urinary Catheterization; D014563:Urodynamics